Monday, November 14, 2022

MolDx Posts Key Questions for Public Meeting on Transplant Tests

Earlier this month, MolDx announced that it would hold (Palmetto + Noridian) two different public meetings on genomic tests for transplant management. Original blog here.  Last week, when these were announced, CareDx stock bounced up and down between $12 and $16.

They have now posted meeting materials - specifically, agendas and key questions.  There is one set for (kidney & liver) tests and one set for (heart & lung tests.)

Find Kidney/Liver documents here.  November 16, 2-4 pm CT.

Find Heart/Lung documents here.  November 17, 2-4 pm CT.

I've also put the 4 PDFs in one cloud zip file here.

See an unofficial transcript of the Kidney meeting, here. Of the Heart/lung meeting, here.